Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 07:55 am Sale |
2024-12-31 | 13G | Annexon, Inc. ANNX |
BCLS I Investco, LP | 5,249,069 4.900% |
-725,647 (-12.15%) |
Filing History |
| 2025-01-31 11:44 am Purchase |
2024-12-31 | 13G | Annexon, Inc. ANNX |
The Vanguard Group | 5,546,918 5.200% |
5,546,918 (New Position) |
Filing History |
| 2024-12-06 11:26 am Purchase |
2024-11-29 | 13G | Annexon, Inc. ANNX |
FMR CORP | 13,930,972 13.100% |
5,369,023 (+62.71%) |
Filing History |
| 2024-11-14 7:21 pm Purchase |
2024-09-30 | 13G | Annexon, Inc. ANNX |
BB BIOTECH AG | 5,157,290 4.900% |
475,000 (+10.14%) |
Filing History |
| 2024-11-14 6:46 pm Sale |
2024-09-30 | 13G | Annexon, Inc. ANNX |
Logos Global Management LP | 2,900,000 2.700% |
-4,044,444 (-58.24%) |
Filing History |
| 2024-11-14 5:30 pm Sale |
2024-09-30 | 13G | Annexon, Inc. ANNX |
BCLS I Investco, LP | 5,974,716 5.500% |
-2,087,003 (-25.89%) |
Filing History |
| 2024-11-14 4:36 pm Purchase |
2024-09-30 | 13G | Annexon, Inc. ANNX |
BIOTECHNOLOGY VALUE FUND L P | 9,027,778 8.400% |
2,027,778 (+28.97%) |
Filing History |
| 2024-11-14 1:22 pm Sale |
2024-09-30 | 13G | Annexon, Inc. ANNX |
PRICE T ROWE ASSOCIATES INC | 1,034,652 1.000% |
-1,842,015 (-64.03%) |
Filing History |
| 2024-11-12 09:50 am Sale |
2024-11-08 | 13G | Annexon, Inc. ANNX |
FMR CORP | 8,561,949 8.103% |
-1,123,452 (-11.60%) |
Filing History |
| 2024-11-12 09:38 am Purchase |
2024-09-30 | 13G | Annexon, Inc. ANNX |
Adage Capital Management L.P. | 3,485,931 3.280% |
3,485,931 (New Position) |
Filing History |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | Annexon, Inc. ANNX |
BLACKROCK INC BLK |
7,647,714 7.200% |
0 (Unchanged) |
Filing History |
| 2024-10-22 6:06 pm Purchase |
2024-09-30 | 13G | Annexon, Inc. ANNX |
BLACKROCK INC BLK |
7,647,714 7.200% |
6,686,671 (+695.77%) |
Filing History |
| 2024-04-22 8:35 pm Purchase |
2024-04-17 | 13G | Annexon, Inc. ANNX |
BB BIOTECH AG | 4,682,290 5.200% |
4,682,290 (New Position) |
Filing History |
| 2024-02-14 8:46 pm Sale |
2023-12-31 | 13G | Annexon, Inc. ANNX |
Venrock Healthcare Capital Partners II, L.P. | 968,679 1.200% |
-3,960,321 (-80.35%) |
Filing History |
| 2024-02-14 4:58 pm Sale |
2023-12-31 | 13G | Annexon, Inc. ANNX |
Citadel Advisors LLC | 1,069,087 1.400% |
-1,431,220 (-57.24%) |
Filing History |
| 2024-02-14 4:26 pm Purchase |
2023-12-31 | 13G | Annexon, Inc. ANNX |
Redmile Group LLC | 8,083,776 9.900% |
3,186,201 (+65.06%) |
Filing History |
| 2024-02-14 3:45 pm Sale |
2023-12-31 | 13G | Annexon, Inc. ANNX |
Fairmount Funds Management LLC | 322,893 0.400% |
-3,358,563 (-91.23%) |
Filing History |
| 2024-02-14 12:43 pm Sale |
2023-12-31 | 13G | Annexon, Inc. ANNX |
Eventide Asset Management, LLC | 0 0.000% |
-3,626,508 (Position Closed) |
Filing History |
| 2024-02-14 10:26 am Purchase |
2023-12-31 | 13G | Annexon, Inc. ANNX |
BIOTECHNOLOGY VALUE FUND L P | 7,000,000 8.900% |
3,219,306 (+85.15%) |
Filing History |
| 2024-02-13 7:23 pm Purchase |
2023-12-31 | 13G | Annexon, Inc. ANNX |
Logos Global Management LP | 6,944,444 8.300% |
3,844,444 (+124.01%) |
Filing History |